Naimish N. Mehta

Assessment of liver regeneration in living donor liver transplantation recipients using computed tomography volumetry-an institutional experience

Sanket Solanki, Abhishek Jayant, Kishan Singh Rawat, Sri Aurobindo Prasad Das et autres

Backgrounds/Aims: Early liver graft regeneration after living donor liver transplantation (LDLT) is critical for patient outcomes, yet prospective volumetric data from Indian recipients remain limited.This study quantifies early graft regeneration and identifies predictors using computed tomography (CT) volumetry.Methods: In this prospective single-center …

in (code pays fourni par la source)

Outcomes of patients with chronic liver disease and symptomatic umbilical hernia presenting to a specialized liver transplant unit

Raghuram Nelluri, Anand Nagar, K. Shiva Kumar, Vinay Kumar Mahala et autres

Abstract Aim Patients with chronic liver disease are predisposed to umbilical hernia due to ascites, sarcopenia, and abdominal wall weakness, with increased perioperative morbidity and mortality from the potential risk of liver decompensation. This study evaluates surgical outcomes of symptomatic umbilical hernia …

in (code pays fourni par la source)

Indian National Association for the Study of Liver (INASL) Guidance Statements for Determining Futility in Liver Transplantation

Praveen Sharma, Ashish Kumar, Subrat Kumar Acharya, Shiv Kumar Sarin et autres

in, ca (code pays fourni par la source)

Hepatoblastoma: An Institutional Experience of this Rare Malignancy in Children

Naimish N. Mehta, Sanket Solanki, Manas Kalra, Sri Aurobindo Prasad Das et autres

in (code pays fourni par la source)

Recurrent Hepatitis A Virus Infection in the Liver Allograft Following Living Donor Transplantation: A Rare Diagnostic Challenge

Karan Kumar, Hrishikesh Sinhasane, Vinay Kumar Mahala, Devender Devender et autres

in (code pays fourni par la source)

Acute graft-Versus-Host Disease Following Living Donor Liver Transplantation: A Rare Complication

Karan Kumar, Vinay Kumar Mahala, Devender, Anil Kumar Gupta et autres

in (code pays fourni par la source)

Sphingomonas paucimobilis Bloodstream Infection in a Post Liver Transplant Patient

Ekadashi Rajni, Anand Kumar Jain, Ayushi Jorwal, Naimish N. Mehta

The health-care sector has undergone remarkable progress along with experiencing challenges such as escalating antimicrobial resistance. Here, we report the successful management of Sphingomonas paucimobilis bloodstream infection in a postliver transplant patient. The objective of sharing this case report is to create …

in (code pays fourni par la source)

Operations for choledochal cysts: A 25-year experience at a tertiary care center in India

Barun Kumar Singh, Romil Jain, Naimish N. Mehta, Shri Aurobindo Prasad Das et autres

Dear Editor, Choledochal cysts (CDCs) are reported primarily in children, with only 20% present in adulthood. Our retrospective review of prospectively maintained data of surgical treatment in 86 adult patients with CDC for operative procedure and outcomes aims to show that surgical …

in (code pays fourni par la source)

Unmasking Hodgkin’s Lymphoma and Its Mimics: Delving into the Interfollicular Zone Beyond Castleman’s Disease

Md Ali Osama, Aditi Aggarwal, Naimish N. Mehta, Praveen Sharma et autres

in (code pays fourni par la source)

Peri-operative outcomes of pancreaticoduodenectomy comparing an isolated Roux loop or single loop for reconstruction: An ambispective observational study

Suvendu Sekhar Jena, Naimish N. Mehta, Amitabh Yadav, Samiran Nundy

in (code pays fourni par la source)

Transforming lives: A triumph of public-private partnership in successful liver transplants

Naimish N. Mehta, Harshil Shaileshbhai Shah, Karan Kumar, Anand Nagar et autres

in (code pays fourni par la source)

IMPACT OF GENDER DISCORDANCE ON OUTCOMES IN LIVING DONOR LIVER TRANSPLANTATION

Naimish N. Mehta, Milind K Akhani, Karan Kumar, Anand Nagar et autres

Liver transplantation (LT) is a highly effective treatment for well-selected recipients with end stage liver disease, fulminant hepatic failure and hepatocellular carcinoma (HCC).The number of patients awaiting LT continues to grow [1]. Unfortunately, the tremendous burden of end-stage liver disease and HCC …

in (code pays fourni par la source)